| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 213 |
| 1 | BEVACIZUMAB | 199 |
| 2 | CARBOPLATIN | 191 |
| 3 | METHOTREXATE SODIUM | 172 |
| 4 | TRASTUZUMAB | 166 |
| 5 | METHOTREXATE | 163 |
| 6 | PREDNISONE | 162 |
| 7 | OMEPRAZOLE MAGNESIUM | 149 |
| 8 | PACLITAXEL | 142 |
| 9 | ASPIRIN | 134 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 3 | 0.0121 |
| 1 | BENZOCAINE AND MENTHOL | 3 | 0.0113 |
| 2 | MINERAL OIL | 13 | 0.0088 |
| 3 | ERDAFITINIB | 10 | 0.0080 |
| 4 | NERATINIB | 17 | 0.0073 |
| 5 | DIMETICONE | 2 | 0.0071 |
| 6 | L-TRYPTOPHAN | 3 | 0.0068 |
| 7 | MIRVETUXIMAB SORAVTANSINE | 11 | 0.0061 |
| 8 | WHITE PETROLATUM | 8 | 0.0055 |
| 9 | SEVELAMER HYDROCHLORIDE | 3 | 0.0052 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 409 |
| 1 | Platinum-based Drug [EPC] | 334 |
| 2 | Kinase Inhibitor [EPC] | 311 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 296 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 281 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 221 |
| 6 | Microtubule Inhibitor [EPC] | 212 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 202 |
| 8 | Aromatase Inhibitor [EPC] | 190 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 189 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Endoglycosidase [EPC] | 12 | 0.0065 |
| 2 | Thyroid Stimulating Hormone [EPC] | 4 | 0.0039 |
| 3 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 4 | Provitamin D2 Compound [EPC] | 89 | 0.0030 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 6 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 7 | Actinomycin [EPC] | 6 | 0.0027 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 189 | 0.0025 |
| 9 | Estrogen Receptor Antagonist [EPC] | 88 | 0.0022 |